- Organizations: STAAR Surgical
Business
Alcon proposes higher bid for STAAR Surgical acquisition
Amended merger agreement increases total equity value of deal by $150 million; meanwhile, a major shareholder is urging against the sale.Business
Alcon to acquire STAAR Surgical
The $1.5 billion deal includes STAAR’s FDA-approved implantable collamer lenses; expected to close within 6 to 12 months.
Business
Staar Surgical appoints new CEO amid leadership changes
Global healthcare executive veteran Stephen C. Farrell takes over the helm as Elizabeth Yeu, MD, is named board chair of STAAR’s Board of Directors.
Archives